Moving now:BRZE +51.70%RVMDW +18.37%LION +14.41%SLS +14.20%|Earnings today (Oct 21):META Β· TSLA Β· LRCX Β· PM Β· SAP β†’|News
Home β€Ί Stock analysis β€Ί OACCW

Oaktree Acquisition Corp. III Life Sciences (OACCW) Stock: Why It's Up Today

Updated Oct 20, 2026, 4:00 PM ET Β· closing price

What changed since yesterday
Compare with peers today

Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Live Oak Acquisition Corp. VI (LOVIU)Archimedes Tech SPAC Partners II (ATII)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)

OACCW jumps 13.1% to $0.90 on 2.8x normal volume. Closed at $0.90, +13.12% vs the prior close of $0.80. Day range $0.90–$0.90, opened at $0.99.

Last close$0.90+13.12%
Day range0.90–0.90
Open0.99
Volume570
52-week range0.66–0.94
Avg volume (20d)388

OACCW daily analysis β€” what happened

A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.

Oct 20, 2026 β€” OACCW jumps 13.1% to $0.90 on 2.8x normal volume

OACCW bull case vs bear case (from the data)

Bull case
  • Latest fiscal-year net income: profit of $7.29M.
Bear case
  • High volatility: average daily move of 13.1% over 20 sessions.
  • Thin trading (under $2M a day on average) can mean wide bid/ask spreads.

OACCW latest news & SEC filings

Every SEC filing by or about OACCW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 16, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001193125-26-423331

Oct 16, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001193125-26-423329

Oct 15, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001193125-26-422266

Oct 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001193125-26-422263

Oct 2, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001193125-26-412601

Sep 21, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001193125-26-396720

Aug 14, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001950677-26-000024

Aug 13, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000312069-26-000209

Aug 12, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001193125-26-346973

Things to know before you trade OACCW

OACCW market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 20, 20260.990.900.900.90570
Oct 16, 20260.990.940.660.80206

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (OACCW) is listed on the Nasdaq and classified by the SEC under β€œBlank Checks”. Its business address is in LOS ANGELES, CA. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2029769.

OACCW board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
David A BerryDirectorOct 22, 2025

Executive officers

NameTitleLatest filing
George Arthur MartinezChief Financial OfficerOct 29, 2025

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

OACCW financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$7.29Mβ€”$-422.08K

Latest balance sheet: total assets $206.54M, total liabilities $8.75M, cash $1.18M (as of Jun 30, 2026).

OACCW earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Blank Checks

Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Live Oak Acquisition Corp. VI (LOVIU)Archimedes Tech SPAC Partners II (ATII)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Bluerock Acquisition Corp. II (BRRKU)Innventure (INV)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)

More on OACCW

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.